Political Interference Disrupts Financial Markets

The news shows continued regulatory uncertainty (FDA leadership turnover, SEC delays on prediction market ETFs, Supreme Court ruling expanding presidential removal power over independent agencies) but no clear evidence of measurable market volatility or repricing directly tied to a specific political interference event as the original prediction described. The situation appears to be an ongoing diffuse uncertainty rather than a sharp, resolved disruption, so neither the original thesis nor the falsification criteria are strongly confirmed.